Similar Tracks
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019
U.S. Food and Drug Administration
Updated "Healthy" Nutrient Content Claim: Final Rule – Webinar – 4/10/2025
U.S. Food and Drug Administration
So, Your NDA Was Approved – Now What?! Post-approval Responsibilities and Obligations- REdI 2020
U.S. Food and Drug Administration
Navigating First ICH Generic Drug Draft Guideline M13A Bioequivalence for IR Solid Oral Dosage Forms
U.S. Food and Drug Administration
FDA Welcomes Dr. Martin A. Makary as 27th Commissioner of Food and Drugs – 4/2/2025
U.S. Food and Drug Administration
Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019
U.S. Food and Drug Administration
Prescription Drug User Fee Act Waivers, Exemptions, and Refunds -Oh My- June 10, 2019
U.S. Food and Drug Administration
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
U.S. Food and Drug Administration
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
U.S. Food and Drug Administration
Pregnancy and Lactation Medication Information for the Healthcare Provider | Learn More
U.S. Food and Drug Administration
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting
U.S. Food and Drug Administration
Nonprescription Drug Product with an Additional Condition for Nonprescription Use
U.S. Food and Drug Administration